Role of antibiotic ligand in nascent peptidedependent ribosome stalling

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 26, 2011, Pages 10496-10501

  Vázquez Laslop, Nora ^a   Klepacki, Dorota ^a   Mulhearn, Debbie C ^a   Ramu, Haripriya ^a   Krasnykh, Olga ^a   Franzblau, Scott ^a   Mankin, Alexander S ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Erythromycin; Ketolides

Indexed keywords

ANTIBIOTIC AGENT; MACROLIDE; NASCENT PEPTIDE; PEPTIDE DERIVATIVE; RNA 23S; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; DRUG STRUCTURE; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENE STRUCTURE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; RIBOSOME; RNA TRANSLATION; SENSOR;

ANTI-BACTERIAL AGENTS; CELL-FREE SYSTEM; LIGANDS; MACROLIDES; MODELS, MOLECULAR; PEPTIDES; PROTEIN BIOSYNTHESIS;

BACTERIA (MICROORGANISMS); EUKARYOTA;

EID: 79960578029     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1103474108     Document Type: Article

References (48)

1. Tenson T, Ehrenberg M (2002) Regulatory nascent peptides in the ribosomal tunnel. Cell 108:591-594. (Pubitemid 34241420)
2. Morris DR, Geballe AP (2000) Upstream open reading frames as regulators of mRNA translation. Mol Cell Biol 20:8635-8642. (Pubitemid 32245897)
3. Ito K, Chiba S, Pogliano K (2010) Divergent stalling sequences sense and control cellular physiology. Biochem Biophys Res Commun 393:1-5.
4. Cruz-Vera LR, Rajagopal S, Squires C, Yanofsky C (2005) Features of ribosome-peptidylt-RNA interactions essential for tryptophan induction of tna operon expression. Mol Cell 19:333-343. (Pubitemid 41074889)
5. Nakatogawa H, Ito K (2002) The ribosomal exit tunnel functions as a discriminating gate. Cell 108:629-636. (Pubitemid 34241424)
6. Vazquez-Laslop N, Ramu H, Klepacki D, Mankin AS (2010) The key role of a conserved and modified rRNA residue in the ribosomal response to the nascent peptide. EMBO J 29:3108-3117.
7. Vazquez-Laslop N, Thum C, Mankin AS (2008) Molecular mechanism of drugdependent ribosome stalling. Mol Cell 30:190-202. (Pubitemid 351626687)
8. Lawrence M, Lindahl L, Zengel JM (2008) Effects on translation pausing of alterations in protein and RNA components of the ribosome exit tunnel. J Bacteriol 190:5862-5869.
9. Cruz-Vera LR, New A, Squires C, Yanofsky C (2007) Ribosomal features essential for tna operon induction: Tryptophan binding at the peptidyl transferase center. J Bacteriol 189:3140-3146. (Pubitemid 46697404)
10. Seidelt B, et al. (2009) Structural insight into nascent polypeptide chain-mediated translational stalling. Science 326:1412-1415.
11. Yang R, Cruz-Vera LR, Yanofsky C (2009) 23S rRNA nucleotides in the peptidyl transferase center are essential for tryptophanase operon induction. J Bacteriol 191:3445-3450.
12. Fulle S, Gohlke H (2009) Statics of the ribosomal exit tunnel: Implications for cotranslational peptide folding, elongation regulation, and antibiotics binding. J Mol Biol 387:502-517.
13. Gong F, Yanofsky C (2002) Instruction of translating ribosome by nascent peptide. Science 297:1864-1867. (Pubitemid 35024344)
14. Luo ZL, Sachs MS (1996) Role of an upstream open reading frame in mediating arginine-specific translational control in Neurospora crassa. J Bacteriol 178:2172-2177.
15. Gaba A, Wang Z, Krishnamoorthy T, Hinnebusch AG, Sachs MS (2001) Physical evidence for distinct mechanisms of translational control by upstream open reading frames. EMBO J 20:6453-6463. (Pubitemid 33078718)
16. Raney A, Baron AC, Mize GJ, Law GL, Morris DR (2000) In vitro translation of the upstream open reading frame in the mammalian mRNA encoding S-adenosylmethionine decarboxylase. J Biol Chem 275:24444-24450.
17. Weisblum B (1995) Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 39:577-585.
18. Lovett PS (1990) Translational attenuation as the regulator of inducible cat genes. J Bacteriol 172:1-6.
19. Menninger JR (1985) Functional consequences of binding macrolides to ribosomes. J Antimicrob Chemother 16(Suppl A):23-34.
20. Tenson T, Lovmar M, Ehrenberg M (2003) The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome. J Mol Biol 330:1005-1014. (Pubitemid 36818898)
21. Horinouchi S,Weisblum B (1980) Posttranscriptional modification of mRNA conformation: Mechanism that regulates erythromycin-induced resistance. Proc Natl Acad Sci USA 77:7079-7083.
22. Gryczan TJ, Grandi G, Hahn J, Grandi R, Dubnau D (1980) Conformational alteration of mRNA structure and the posttranscriptional regulation of erythromycin-induced drug resistance. Nucleic Acids Res 8:6081-6097. (Pubitemid 11100306)
23. Mayford M, Weisblum B (1989) ermC leader peptide. Amino acid sequence critical for induction by translational attenuation. J Mol Biol 206:69-79. (Pubitemid 19095542)
24. Vázquez-Laslop N, Ramu H, Mankin AS (2011) Nascent peptide-mediated ribosome stalling promoted by antibiotics. Ribosomes: Structure, Function, and Dynamics, eds MV Rodnina, R Green, and W Wintermeyer (Springer-Verlag, Vienna).
25. Ettayebi M, Prasad SM, Morgan EA (1985) Chloramphenicol-erythromycin resistance mutations in a 23S rRNA gene of Escherichia coli. J Bacteriol 162:551-557. (Pubitemid 15062428)
26. Moazed D, Noller HF (1987) Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA. Biochimie 69:879-884. (Pubitemid 18043530)
27. Schlunzen F, et al. (2001) Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413:814-821. (Pubitemid 33026843)
28. Tu D, Blaha G, Moore PB, Steitz TA (2005) Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance. Cell 121:257-270. (Pubitemid 40546393)
29. Dunkle JA, Xiong L, Mankin AS, Cate JH (2010) Structures of the Escherichia coli ribosome with antibiotics bound near the peptidyl transferase center explain spectra of drug action. Proc Natl Acad Sci USA 107:17152-17157.
30. Bulkley D, Innis CA, Blaha G, Steitz TA (2010) Revisiting the structures of several antibiotics bound to the bacterial ribosome. Proc Natl Acad Sci USA 107:17158-17163.
31. Pestka S, et al. (1976) Induction of erythromycin resistance in Staphyloccus aureus by erythromycin derivatives. Antimicrob Agents Chemother 9:128-130.
32. Mayford M, Weisblum B (1990) The ermC leader peptide: Amino acid alterations leading to differential efficiency of induction by macrolide-lincosamide-streptogramin B antibiotics. J Bacteriol 172:3772-3779. (Pubitemid 20213355)
33. Allen NE (1977) Macrolide resistance in Staphylococcus aureus: Inducers of macrolide resistance. Antimicrob Agents Chemother 11:669-674.
34. Rosato A, Vicarini H, Bonnefoy A, Chantot JF, Leclercq R (1998) A new ketolide, HMR 3004, active against streptococci inducibly resistant to erythromycin. Antimicrob Agents Chemother 42:1392-1396. (Pubitemid 28257638)
35. Bryskier A (2000) Ketolides-telithromycin, an example of a new class of antibacterial agents. Clin Microbiol Infect 6:661-669.
36. Hartz D, McPheeters DS, Traut R, Gold L (1988) Extension inhibition analysis of translation initiation complexes. Methods Enzymol 164:419-425.
37. Sachs MS, et al. (2002) Toeprint analysis of the positioning of translation apparatus components at initiation and termination codons of fungal mRNAs. Methods 26:105-114. (Pubitemid 34969572)
38. Muto H, Nakatogawa H, Ito K (2006) Genetically encoded but nonpolypeptide prolyltRNA functions in the A site for SecM-mediated ribosomal stall. Mol Cell 22:545-552.
39. Asai T, Zaporojets D, Squires C, Squires CL (1999) An Escherichia coli strain with all chromosomal rRNA operons inactivated: Complete exchange of rRNA genes between bacteria. Proc Natl Acad Sci USA 96:1971-1976. (Pubitemid 29117852)
40. Bollenbach T, Quan S, Chait R, Kishony R (2009) Nonoptimal microbial response to antibiotics underlies suppressive drug interactions. Cell 139:707-718.
41. Hütter R, Poralla K, Zachau HG, Zahner H (1966) Metabolic products of microorganisms. 5l. On the mechanism of action of borrelidin-inhibition of the threonine incorporation in sRNA. Biochem Z 344:190-196.
42. Garza-Ramos G, Xiong L, Zhong P, Mankin A (2001) Binding site of macrolide antibiotics on the ribosome: New resistance mutation identifies a specific interaction of ketolides with rRNA. J Bacteriol 183:6898-6907. (Pubitemid 33064204)
43. Voss NR, Gerstein M, Steitz TA, Moore PB (2006) The geometry of the ribosomal polypeptide exit tunnel. J Mol Biol 360:893-906. (Pubitemid 43993916)
44. Zhu ZJ, et al. (2008) Structure-activity relationships of macrolides against Mycobacterium tuberculosis. Tuberculosis 88(Suppl 1):S49-63.
45. Shimizu Y, et al. (2001) Cell-free translation reconstituted with purified components. Nat Biotechnol 19(8):751-755. (Pubitemid 32729537)
46. Ohashi H, Shimizu Y, Ying BW, Ueda T (2007) Efficient protein selection based on ribosome display system with purified components. Biochem Biophys Res Commun 352:270-276. (Pubitemid 44821125)
47. Douthwaite S, Powers T, Lee JY, Noller HF (1989) Defining the structural requirements for a helix in 23S ribosomal RNA that confers erythromycin resistance. J Mol Biol 209:655-665. (Pubitemid 20046123)
48. Zaporojets D, French S, Squires CL (2003) Products transcribed from rearranged rrn genes of Escherichia coli can assemble to form functional ribosomes. J Bacteriol 185:6921-6927. (Pubitemid 37444494)